Assembly Biosciences, Inc. (ASMB)
28.42
-1.43
(-4.79%)
USD |
NASDAQ |
Apr 10, 16:00
28.40
-0.02
(-0.05%)
After-Hours: 20:00
Assembly Biosciences Total Liabilities (Quarterly) : 51.54M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | 552.44M |
| TELA Bio, Inc. | 75.71M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
| Savara, Inc. | 50.30M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 258.29M |
| Shareholders Equity (Quarterly) | 206.75M |
| Debt to Equity Ratio | 0.0127 |
| Current Ratio | 5.218 |
| Net Debt Paydown Yield | -0.04% |